Jan. 26 at 9:22 AM
$ACXP Why composition-of-matter patents are 🔑 so valuable
In pharma, patents fall into three tiers:
1️⃣ Composition-of-matter (⭐ strongest)
Protects the molecule itself — across all indications
Very difficult for competitors to design around
Gold standard Big Pharma looks for in licensing & M&A
👉 This patent Acurx now has in Australia.
2️⃣ Use patents
Protect use of a molecule for a specific indication
Same molecule could be used for other diseases
Weaker protection
3️⃣ Formulation / method patents
Cover dosing, formulation, or manufacturing
Easier to work around
Primarily defensive IP
What this means for Acurx
💊 Strong product protection
ACX-375C protected at the molecular level
High barrier to generic competition
🌍 Expanding global IP footprint
Granted in U.S., Japan, Israel, India, Australia
Key pharma markets, attractive to partners
🤝 Increased licensing / acquisition appeal
Phase 3-ready asset + composition-of-matter IP
= highly attractive deal profile
